Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the Impact of 2D MRI Slice Orientation and Location on Alzheimer's Disease Diagnosis Using a Lightweight Convolutional Neural Network.

Journal of imaging·2025
See all related articles

Related Experiment Video

Updated: Jul 11, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

A Dual Stream Deep Learning Framework for Alzheimer's Disease Detection Using MRI Sonification.

Nadia A Mohsin1, Mohammed H Abdul Ameer2

  • 1Department of Computer Science, Faculty of Computer Science and Mathematics, University of Kufa, Najaf 54001, Iraq.

Journal of Imaging
|January 27, 2026
PubMed
Summary

This study introduces MRI sonification to diagnose Alzheimer's Disease (AD). Combining audio and visual MRI data significantly improves diagnostic accuracy for AD and Mild Cognitive Impairment (MCI).

Keywords:
Alzheimer diseaseMRIdeep learningmultimodalsonification

More Related Videos

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's Disease (AD) is a progressive brain disorder impacting millions globally, characterized by memory loss and cognitive decline.
  • Magnetic Resonance Imaging (MRI) is a key diagnostic tool, but current methods primarily use visual data, overlooking other potential features.
  • Exploring novel methods to enhance AD diagnosis is crucial for early intervention and patient management.

Purpose of the Study:

  • To investigate the diagnostic potential of MRI sonification as a complementary approach to conventional image-based methods for Alzheimer's Disease.
  • To develop and evaluate a novel dual-stream multimodal framework integrating 2D MRI slices and their audio representations.

Main Methods:

  • A novel dual-stream multimodal framework was developed, transforming 2D MRI slices into audio signals using Gabor filtering and a Hilbert space-filling curve.
  • The framework processed image and audio modalities using a Convolutional Neural Network (CNN) and YAMNet, respectively.
  • Data fusion was achieved through logistic regression to combine features from both modalities.

Main Results:

  • The multimodal framework achieved high accuracy in distinguishing between Alzheimer's Disease (AD) and Cognitively Normal (CN) subjects (98.2%).
  • The system demonstrated strong performance in differentiating AD from Mild Cognitive Impairment (MCI) (94%) and MCI from CN subjects (93.2%).

Conclusions:

  • MRI sonification offers a promising new avenue for extracting complementary diagnostic information from imaging data.
  • This approach highlights the potential of audio transformation of imaging data for enhanced feature extraction and classification in neurological disorders.
  • The developed multimodal framework shows significant potential for improving the accuracy of Alzheimer's Disease diagnosis.